• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Biliary microbiote in cholecystectomized patients: Review of empirical antibiotherapy].胆囊切除患者的胆道微生物群:经验性抗菌治疗综述
Rev Esp Quimioter. 2019 Oct;32(5):426-431. Epub 2019 Sep 18.
2
Clinical aspects of bile culture in patients undergoing laparoscopic cholecystectomy.接受腹腔镜胆囊切除术患者胆汁培养的临床情况
Medicine (Baltimore). 2018 Jun;97(26):e11234. doi: 10.1097/MD.0000000000011234.
3
[Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection].[胆道感染患者胆汁培养的微生物学研究及抗菌药敏分析]
Korean J Gastroenterol. 2008 Apr;51(4):248-54.
4
[Pathogens' distribution and changes of antimicrobial resistance in the bile of acute biliary tract infection patients].[急性胆道感染患者胆汁中病原菌分布及耐药性变化]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):24-31. doi: 10.3760/cma.j.cn112139-20200717-00559.
5
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.在实验性脓毒症小鼠模型中,接种物对产超广谱β-内酰胺酶(ESBL)和非产 ESBL 大肠埃希菌的阿莫西林克拉维酸、哌拉西林他唑巴坦和亚胺培南疗效的影响。
Antimicrob Agents Chemother. 2013 May;57(5):2109-13. doi: 10.1128/AAC.02190-12. Epub 2013 Feb 25.
6
Microbiological etiology and current resistance patterns in acute calculous cholecystitis.急性结石性胆囊炎的微生物病因学和当前耐药模式。
Cir Esp (Engl Ed). 2024 Jul;102(7):373-380. doi: 10.1016/j.cireng.2024.04.003. Epub 2024 Apr 23.
7
Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing .产超广谱β-内酰胺酶治疗.
Microb Drug Resist. 2019 Oct;25(8):1132-1141. doi: 10.1089/mdr.2019.0065. Epub 2019 May 20.
8
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.哌拉西林-他唑巴坦与环丙沙星加阿莫西林治疗肝移植后感染性发作的比较
J Antimicrob Chemother. 2003 Dec;52(6):993-1000. doi: 10.1093/jac/dkg463. Epub 2003 Oct 29.
9
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.比较产超广谱β-内酰胺酶和不产超广谱β-内酰胺酶大肠埃希菌分离株的接种物效应对阿莫西林克拉维酸和哌拉西林他唑巴坦抗菌活性的影响。
Clin Microbiol Infect. 2010 Feb;16(2):132-6. doi: 10.1111/j.1469-0691.2009.02893.x. Epub 2009 Jul 15.
10
Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing and isolated in selected hospitals of Anyigba, Nigeria.尼日利亚阿尼耶巴选定医院中产超广谱β-内酰胺酶和 的分离株及其耐药性分析。
Afr Health Sci. 2021 Jun;21(2):505-512. doi: 10.4314/ahs.v21i2.4.

引用本文的文献

1
Impact of empiric antibiotic therapy on the clinical outcome of acute calculous cholecystitis.经验性抗生素治疗对急性结石性胆囊炎临床结局的影响。
Langenbecks Arch Surg. 2023 Aug 29;408(1):345. doi: 10.1007/s00423-023-03063-4.

本文引用的文献

1
Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.东京指南 2018:急性胆管炎和胆囊炎的抗菌治疗。
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16. doi: 10.1002/jhbp.518. Epub 2018 Jan 9.
2
[Incidence of bacteria from cultures of bile and gallbladder wall of laparoscopic cholecystectomy patients in the University Hospital "Dr. José Eleuterio González"].["何塞·埃莱乌特里奥·冈萨雷斯博士大学医院腹腔镜胆囊切除术患者胆汁和胆囊壁培养物中细菌的发生率"]
Cir Cir. 2017 Nov-Dec;85(6):515-521. doi: 10.1016/j.circir.2016.10.030. Epub 2017 Jan 16.
3
2016 WSES guidelines on acute calculous cholecystitis.2016年WSES急性结石性胆囊炎指南。
World J Emerg Surg. 2016 Jun 14;11:25. doi: 10.1186/s13017-016-0082-5. eCollection 2016.
4
[Role of bacteriobilia in postoperative complications].[胆系感染在术后并发症中的作用]
Rev Esp Quimioter. 2016 Jun;29(3):123-9. Epub 2016 Apr 8.
5
Microbiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies.胆汁的微生物学评估及相应的抗生素治疗:一项符合STROBE标准的1401例内镜逆行胆管造影术观察性研究
Medicine (Baltimore). 2016 Mar;95(10):e2390. doi: 10.1097/MD.0000000000002390.
6
[Pylephlebitis due to Aeromonas caviae secondary to acute cholecystitis].急性胆囊炎继发豚鼠气单胞菌引起的门静脉炎
Enferm Infecc Microbiol Clin. 2016 Jan;34(1):70-2. doi: 10.1016/j.eimc.2015.04.011. Epub 2015 May 29.
7
Bactibilia and Antibiotic Resistance in Elective Cholecysctectomy: An Updated Ecologic Survey.择期胆囊切除术中的胆源性菌血症与抗生素耐药性:一项最新的生态学调查
Surg Infect (Larchmt). 2015 Jun;16(3):287-92. doi: 10.1089/sur.2014.023. Epub 2015 Apr 21.
8
[Surgical site infections: antibiotic prophylaxis in surgery].手术部位感染:手术中的抗生素预防
Enferm Infecc Microbiol Clin. 2014 Jan;32(1):48-53. doi: 10.1016/j.eimc.2013.11.003. Epub 2013 Dec 17.
9
TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis.急性胆管炎和胆囊炎的 TG13 现行术语、病因和流行病学。
J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):8-23. doi: 10.1007/s00534-012-0564-0.
10
Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience.胆汁微生物学和抗生素药敏性的变化趋势:超过 12 年的经验。
Infection. 2013 Feb;41(1):93-102. doi: 10.1007/s15010-012-0358-y. Epub 2012 Nov 21.

胆囊切除患者的胆道微生物群:经验性抗菌治疗综述

[Biliary microbiote in cholecystectomized patients: Review of empirical antibiotherapy].

作者信息

Gil Fortuño M, Granel Villach L, Sabater Vidal S, Soria Martín R, Martínez Ramos D, Escrig Sos J, Moreno Muñoz R, Igual Adell R

机构信息

María Gil Fortuño, Servicio de Microbiología y Parasitología. Hospital General Universitari de Castelló. Avenida de Benicàssim, sn. 12004, Castelló, Spain.

出版信息

Rev Esp Quimioter. 2019 Oct;32(5):426-431. Epub 2019 Sep 18.

PMID:31531672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6790889/
Abstract

OBJECTIVE

Cholecystitis is an important cause of hospital admission. In moderate or severe cholecystitis, the delay in treatment can lead to serious complications. Our objective is to analyze the microorganisms isolated in bile from cholecystectomized patients and their sensitivity pattern, to evaluate the empirical treatment in those cases in which the surgical removal of the gallbladder should be delayed.

METHODS

Prospective descriptive study of biliary cultures of patients undergoing cholecystectomy from May 2013 to February 2015, in the Surgery Department of the Hospital General Universitari de Castelló.

RESULTS

We studied 196 patients, 83 women (42.3%) and 113 men (57.7%), with an average age of 61.5 years. The most used antibiotics as empiric treatment were piperacillin/tazobactam (77.8%) and amoxicillin/clavulanic (14.8%). In 46.4% of patients (91/196) bile cultures were positive. 165 microorganisms were isolated. The majority were Gram-negative bacilli (60.5%), mainly of the Enterobacterales order (91/54.5%), with Escherichia coli being the most frequent microorganism (24%) followed by Klebsiella spp. (12.5%). 3 E. coli with extended-spectrum beta-lactamase (ESBL) and 1 K. pneumoniae with ESBL were isolated. Microorganisms producing carbapenemase and methicillin-resistant Staphylococcus aureus were not isolated.

CONCLUSIONS

The bile microbiota, with a predominance of Enterobacterales is similar to that found in european studies..

摘要

目的

胆囊炎是住院的重要原因。在中度或重度胆囊炎中,治疗延迟可导致严重并发症。我们的目的是分析胆囊切除患者胆汁中分离出的微生物及其药敏模式,以评估在应延迟胆囊手术切除的病例中的经验性治疗。

方法

对2013年5月至2015年2月在卡斯特利翁大学综合医院外科接受胆囊切除术的患者的胆汁培养进行前瞻性描述性研究。

结果

我们研究了196例患者,其中83例女性(42.3%)和113例男性(57.7%),平均年龄61.5岁。作为经验性治疗最常用的抗生素是哌拉西林/他唑巴坦(77.8%)和阿莫西林/克拉维酸(14.8%)。46.4%的患者(91/196)胆汁培养呈阳性。分离出165种微生物。大多数是革兰氏阴性杆菌(60.5%),主要是肠杆菌目(91/54.5%),其中大肠埃希菌是最常见的微生物(24%),其次是克雷伯菌属(12.5%)。分离出3株产超广谱β-内酰胺酶(ESBL)的大肠埃希菌和1株产ESBL的肺炎克雷伯菌。未分离出产碳青霉烯酶的微生物和耐甲氧西林金黄色葡萄球菌。

结论

以肠杆菌目为主的胆汁微生物群与欧洲研究中发现的相似。